Western European Molecular Diagnostics Market, 2015 Forecast to 2020

Across all segments of in-vitro diagnostics, including research and further upcoming disruptive technologies across the life sciences landscape—research tools, clinical diagnostics, and pharma—disruptive technologies transform the complete healthcare decision making and diagnostics trend. However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics companies that fail to capitalize on the opportunities presented through emerging trends and disruptive new business models become late entrants in a market, generally before redundancy from me-too products occurs and take market share. This study provides an elaborate structure of the European healthcare system , which is supporting the growth of molecular diagnostics, the reimbursement strategies, and policies promoting the acceptance of MDx assays across applications. This information would be suitable to understand the current need and the diagnostics style adoption among the patient population for better outcomes and clinical decision making. Specific challenges shared in this study include the shifting payment landscape which pays for services, change in business models, and challenges in innovative therapeutics and molecular diagnostics to align with value-based care models.
Published: 2 Jan 2017

Western European Molecular Diagnostics Market, 2015 Forecast to 2020

Prevalence and Prevention Driving Healthcare in Europe Toward Molecular Diagnostics Expansion and Innovation

Across the In vitro diagnostics Segment , including research and further upcoming disruptive technologies Across the Life Sciences landscape, including research tools, clinical diagnostics and pharma, disruptive technologies transform the complete the Healthcare decision making , and diagnostics trend .  However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside of their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics Companies who fail to capitalize on opportunities presented through emerging trends and disruptive new business models become late entrants in a market that generally before redundancy from me-too products occurs and takes market share.  
This report is an elaborate structure of the European Healthcare system , which is supporting the growth of Molecular diagnostics , the reimbursement strategies and policies promoting the acceptance of MDx assays across application , This information would be suitable to understand the current need and the diagnostics style adaptation among the patient population for better outcome and clinical decision making. Specific challenges shared in this report  include shifting payment landscape (business models) who pays for services, challenge monetize Innovative Therapeutics & Molecular Diagnostics to align with Value based Care Models

Key Questions

  • Will the molecular diagnostics market disrupt current businesses or create growth opportunities? What do companies need to know?
  • What would be the trending market segments and technology that are revolutionizing molecular diagnostics?
  • What are some of the most disruptive products by disease and the key market focus with technological advancements?
  • What are the gaps in the market that encourage penetration and provide opportunities to new entrants?
  • What is the future of the molecular diagnostics market in Western Europe? What should the market participants do to succeed?
  • Are the products and services offered currently meeting customers’ needs or is there a need for additional development?

Features of this Research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..